ArticleFrontiers in pharmacology2021

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling.

Yun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.